Skip to main content

Bladder Cancer Clinical Trials

Review the bladder cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 151-174 of 174

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Status: Active
Location: 3 locations
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-04)
Status: Active
Location: 3 locations
Mood Alterations in the Patients with Non-Muscle Invasive Bladder Cancer Treated with Bacillus Calmete-Guerin
Status: Active
Location: 2 locations
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Blue Light Cystoscopy With Cysview® Registry
Status: Active
Location: 12 locations
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Status: Active
Location: 7 locations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Status: Active
Location: 7 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Status: Active
Location: 5 locations
The Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) for Bladder Cancer Study 2
Status: Active
Location: 4 locations
Predicting BCG Response
Status: Active
Location: 2 locations
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Status: Active
Location: 2 locations
Collecting and Studying Blood and Tissue Samples from Patients with Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
Status: Active
Location: 2 locations
Pan-tumor MRD Study
Status: Active
Location: 2 locations
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Measuring Surgical Recovery in Participants Undergoing Radical Cystectomy
Status: Active
Location: 15 locations
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Status: Active
Location: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Status: Active
Location: See ClinicalTrials.gov
Circulating Tumor DNA Exposure in Peripheral Blood
Status: Active
Location: See ClinicalTrials.gov
Characterizing the Microvascular Environment of Bladder Cancer with Super-Resolution Ultrasound Localization Microscopy
Status: Active
Location: Duke University Medical Center, Durham, North Carolina